P. Drings

4.8k total citations
195 papers, 3.3k citations indexed

About

P. Drings is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, P. Drings has authored 195 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 84 papers in Pulmonary and Respiratory Medicine and 49 papers in Molecular Biology. Recurrent topics in P. Drings's work include Lung Cancer Treatments and Mutations (60 papers), Lung Cancer Research Studies (58 papers) and Neuroendocrine Tumor Research Advances (33 papers). P. Drings is often cited by papers focused on Lung Cancer Treatments and Mutations (60 papers), Lung Cancer Research Studies (58 papers) and Neuroendocrine Tumor Research Advances (33 papers). P. Drings collaborates with scholars based in Germany, Austria and Switzerland. P. Drings's co-authors include M Volm, Klaus Kayser, Werner Rittgen, Angela Risch, Helmut Bartsch, Hendrik Dienemann, Peter Schmezer, I. Vogt‐Moykopf, H. Bülzebruck and B. Spiegelhalder and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.

In The Last Decade

P. Drings

185 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Drings Germany 32 1.7k 1.1k 1.1k 492 473 195 3.3k
Yasutsuna Sasaki Japan 35 2.6k 1.5× 1.2k 1.1× 1.2k 1.2× 287 0.6× 190 0.4× 193 4.0k
Lionel D. Lewis United States 36 1.7k 1.0× 1.4k 1.3× 806 0.7× 445 0.9× 252 0.5× 167 4.2k
Adnan Ghafoor United States 2 1.5k 0.9× 891 0.8× 907 0.8× 512 1.0× 282 0.6× 3 3.2k
Antoinette J. Wozniak United States 31 3.1k 1.8× 988 0.9× 2.3k 2.2× 421 0.9× 447 0.9× 102 4.6k
Masashi Ando Japan 31 2.0k 1.2× 688 0.6× 954 0.9× 774 1.6× 204 0.4× 206 3.6k
Enrique Espinosa Spain 32 1.8k 1.1× 1.5k 1.4× 773 0.7× 664 1.3× 207 0.4× 232 4.2k
René Bruno France 35 2.8k 1.6× 913 0.8× 1.0k 1.0× 700 1.4× 182 0.4× 128 4.7k
Lisa Wang Canada 42 1.8k 1.1× 1.7k 1.6× 1.2k 1.1× 647 1.3× 477 1.0× 191 5.1k
Raghunadharao Digumarti India 25 2.4k 1.4× 1.1k 1.0× 2.5k 2.3× 551 1.1× 602 1.3× 150 5.1k
Antonius A. Miller United States 36 2.4k 1.4× 1.1k 1.0× 1.8k 1.7× 261 0.5× 938 2.0× 105 4.1k

Countries citing papers authored by P. Drings

Since Specialization
Citations

This map shows the geographic impact of P. Drings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Drings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Drings more than expected).

Fields of papers citing papers by P. Drings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Drings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Drings. The network helps show where P. Drings may publish in the future.

Co-authorship network of co-authors of P. Drings

This figure shows the co-authorship network connecting the top 25 collaborators of P. Drings. A scholar is included among the top collaborators of P. Drings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Drings. P. Drings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dally, Heike, Lutz Edler, B Jäger, et al.. (2008). Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients. International Journal of Cancer. 124(7). 1669–1674. 42 indexed citations
2.
3.
Cui, Yunhai, Angela Risch, P. Drings, et al.. (2004). Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics. 14(4). 213–223. 60 indexed citations
4.
Drings, P.. (2004). IALT-Studie. Der Internist. 46(2). 214–215. 1 indexed citations
5.
Wikman, Harriet, Peter Schmezer, B. Spiegelhalder, et al.. (2001). Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics. 11(2). 157–168. 72 indexed citations
6.
Gatzemeier, U., J P Kleisbauer, P. Drings, et al.. (2000). Lenograstim as Support for ACE Chemotherapy of Small-Cell Lung Cancer. American Journal of Clinical Oncology. 23(4). 393–400. 25 indexed citations
7.
Manegold, C., et al.. (1997). Das diffuse maligne Pleuramesotheliom: Diagnostik, Therapie, Prognose. Oncology Research and Treatment. 20(1). 64–69. 1 indexed citations
8.
Manegold, C., P. Drings, U. Gatzemeier, et al.. (1996). Lobaplatin (D-19466) in Patients with Advanced Non-Small-Cell Lung Cancer: A Trial of the Association for Medical Oncology (AIO) Phase II Study Group. Oncology Research and Treatment. 19(3). 248–251. 7 indexed citations
9.
Drings, P., G. Brittinger, Gerhard Gaedicke, et al.. (1995). Die moderne Krebsbehandlung: Wissenschaftlich begründete Verfahren und Methoden mit unbewiesener Wirksamkeit. Oncology Research and Treatment. 18(2). 158–162. 7 indexed citations
10.
11.
Drings, P., I Günther, U. Gatzemeier, et al.. (1992). Final Evaluation of a Phase II Study on the Effect of Edelfosine (an Ether Lipid) in Advanced Non-Small-Cell Bronchogenic Carcinoma. Oncology Research and Treatment. 15(5). 375–382. 17 indexed citations
12.
Eck, Hans‐Peter, Thomas Mertens, Gerd Fätkenheuer, et al.. (1992). T4+ cell numbers are correlated with plasma glutamate and cystine levels: association of hyperglutamataemia with immunodeficiency in diseases with different aetiologies. International Immunology. 4(1). 7–13. 24 indexed citations
13.
Manegold, C., et al.. (1992). Oral ifosfamide-mesna: A clinical investigation in advanced non-small-cell lung cancer. Annals of Oncology. 3(9). 723–726. 10 indexed citations
14.
Wolf, M., Rolf Holle, K. Hans, P. Drings, & K. Havemann. (1991). Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival. British Journal of Cancer. 63(6). 986–992. 107 indexed citations
15.
Wagner, Thomas & P. Drings. (1987). Pharmacokinetics and Bioavailability of Oral Ifosfamide. PubMed. 36(5). 53–59. 28 indexed citations
16.
Drings, P., et al.. (1986). EPICO für die Behandlung des kleinzelligen Bronchialkarzinoms. Oncology Research and Treatment. 9(1). 14–20. 4 indexed citations
17.
18.
Kaick, G. van, et al.. (1973). [Chronic myeloid leukemia 27 years after Thorotrast incorporation].. PubMed. 145(5). 582–7. 1 indexed citations
19.
Drings, P., et al.. (1973). [Course study of Fanconi's anemia in an adult].. PubMed. 79. 477–81. 5 indexed citations
20.
Drings, P. & Eberhard Harbers. (1969). Untersuchungen an Nucleohistonen: V. Veränderungen im Chromatin der Granulocyten bei der „Linksverschiebung“. Journal of Molecular Medicine. 47(2). 102–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasutsuna Sasaki Breakdown of academic impact, for papers by Lionel D. Lewis Breakdown of academic impact, for papers by Adnan Ghafoor Breakdown of academic impact, for papers by Antoinette J. Wozniak Breakdown of academic impact, for papers by Masashi Ando Breakdown of academic impact, for papers by Enrique Espinosa Breakdown of academic impact, for papers by René Bruno Breakdown of academic impact, for papers by Lisa Wang Breakdown of academic impact, for papers by Raghunadharao Digumarti Breakdown of academic impact, for papers by Antonius A. Miller
Rankless by CCL
2026